Inter Pharma PCL (BKK:IP)

Inter Pharma PCL Revenue

Inter Pharma PCL had revenue of 562.08M THB in the quarter ending March 31, 2026, with 5.33% growth. This brings the company's revenue in the last twelve months to 2.24B, up 14.52% year-over-year. In the year 2025, Inter Pharma PCL had annual revenue of 2.21B with 15.80% growth.

• Revenue (ttm): 2.24B
• Revenue Growth: +14.52%
• P/S Ratio: 1.12
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.52B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.21B	302.11M	15.80%
Dec 31, 2024	1.91B	113.17M	6.29%
Dec 31, 2023	1.80B	264.33M	17.23%
Dec 31, 2022	1.53B	613.46M	66.61%
Dec 31, 2021	920.98M	474.05M	106.07%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error